Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion
Acta Ophthalmologica, 08/16/2012
Hadjistilianou T et al. – SOAIM is effective for the treatment of macular retinoblastoma, when performed in adequate settings by operators with skills in angiographic diagnosis and treatment of intracranial vascular diseases. Moreover, Melphalan selectively delivered in the ophthalmic artery may allow the salvation of eyes which should otherwise be enucleated, showing a very low rate of complications due to local and systemic toxicity.